You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

jnj-56136379

Showing 1 - 5 of 5
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatitis B Trial in Worldwide (JNJ-73763989, JNJ-56136379, Entecavir (ETV))

Active, not recruiting
  • Hepatitis B
  • Baltimore, Maryland
  • +9 more
Jan 17, 2023

Healthy Trial (JNJ-56136379, Bictegravir (BIC) plus Emtricitabine (FTC) plus Tenofovir Alafenamide (TAF))

Withdrawn
  • Healthy
  • JNJ-56136379
  • Bictegravir (BIC) plus Emtricitabine (FTC) plus Tenofovir Alafenamide (TAF)
  • (no location specified)
Jul 12, 2021

Hepatic Impairment Trial in Munchen (JNJ-56136379)

Completed
  • Hepatic Impairment
  • JNJ-56136379
  • Munchen, Germany
    APEX GmbH
Apr 19, 2021

Hepatitis B Trial in Worldwide (JNJ-56136379, Placebo, NA (ETV or TDF))

Completed
Has Results
  • Hepatitis B
  • JNJ-56136379
  • +2 more
  • Bakersfield, California
  • +75 more
Oct 24, 2022

Healthy Trial in Merksem (JNJ-56136379, Itraconazole)

Completed
  • Healthy
  • Merksem, Belgium
    Clinical Pharmacology Unit
Nov 26, 2019